- Home
- »
- Medical Devices
- »
-
Healthcare Contract Packaging Services Market Report, 2033GVR Report cover
Healthcare Contract Packaging Services Market (2025 - 2033) Size, Share & Trends Analysis Report By Service (Primary Packaging, Secondary Packaging, Tertiary Packaging), By Product Type, By End Use, By Region, And Segment Forecasts
- Report ID: GVR-4-68040-794-5
- Number of Report Pages: 150
- Format: PDF
- Historical Range: 2021 - 2023
- Forecast Period: 2025 - 2033
- Industry: Healthcare
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Healthcare Contract Packaging Services Market Summary
The global healthcare contract packaging services market size was valued at USD 23.65 billion in 2024 and is projected to reach USD 61.14 billion by 2033, growing at a CAGR of 11.36% from 2025 to 2033. The market is driven due to the increasing demand for outsourcing packaging operations by pharmaceutical, biotechnology, and medical device companies to improve efficiency, ensure regulatory compliance, and reduce operational costs.
Key Market Trends & Insights
- North America Healthcare Contract Packaging Services Market held the largest share of 38.33% of the global market in 2024.
- The U.S. healthcare contract packaging services industry in the India is expected to grow significantly over the forecast period.
- By service, the primary packaging segment led the market with the largest revenue share of 81.25% in 2024.
- Based on product type, the blister packs segment led the market with the largest revenue share in 2024.
Market Size & Forecast
- 2024 Market Size: USD 23.65 Billion
- 2033 Projected Market Size: USD 61.14 Billion
- CAGR (2025-2033): 11.36%
- North America: Largest market in 2024
- Asia-Pacific: Fastest growing market
Furthermore, the market is driven by the increasing outsourcing of packaging operations by pharmaceutical, biotechnology, and medical device companies seeking to enhance operational efficiency and focus on core competencies such as R&D and commercialization. Rising regulatory complexity across regions has made compliance more demanding, prompting companies to rely on specialized contract packagers with expertise in Good Manufacturing Practices (GMP) and quality assurance. In addition, the surge in drug development, especially in biologics and specialty pharmaceuticals, has led to greater demand for sophisticated packaging formats capable of maintaining product integrity, stability, and safety.
The growing emphasis on patient-centric and sustainable packaging solutions. With the healthcare industry shifting toward personalized medicine and self-administration drug formats, the need for convenient, tamper-evident, and easy-to-use packaging has intensified. Simultaneously, environmental concerns and regulatory pressure are encouraging the adoption of eco-friendly and recyclable packaging materials, creating new opportunities for innovation. Furthermore, advancements in automation, digital traceability, and smart packaging technologies-such as RFID, barcoding, and serialization-are enhancing supply chain visibility and security, further accelerating the market’s growth.
Opportunity Analysis
The global Healthcare Contract Packaging Services Market offers substantial growth opportunities driven by rising outsourcing trends, the expansion of biologics and personalized medicines, and the growing need for advanced and compliant packaging solutions. Increasing demand for sustainable and eco-friendly materials, along with the integration of smart packaging technologies such as RFID and QR code tracking, presents lucrative avenues for innovation. Moreover, the surge in biopharmaceutical production, globalization of clinical trials, and the shift toward patient-centric packaging formats create additional prospects for contract packagers to provide value-added services, streamline supply chains, and strengthen partnerships with pharmaceutical and medical device manufacturers.
Service Insights
On the basis of service segment, the market is segmented into Primary Packaging, Secondary Packaging, and Tertiary Packaging. The primary packaging segment gained the largest market share of 56.57% in 2024. The segment growth is primarily attributable to the rising demand for high-quality, sterile, and protective packaging solutions that ensure the safety, efficacy, and stability of pharmaceutical and biopharmaceutical products. The increasing production of complex biologics, injectables, and single-dose formulations has driven the need for advanced primary packaging formats such as vials, prefilled syringes, blister packs, and ampoules.
The secondary packaging segment is expected to witness considerable growth owing to the increasing emphasis on product differentiation, branding, and enhanced protection during transportation and storage. As pharmaceutical and medical device companies expand their global distribution networks, the need for robust, compliant, and tamper-evident secondary packaging solutions has intensified.
Product Type Insights
On the basis of the product type segment, the market is segmented into blister packs, bottles (plastic / glass), vials & ampoules, pre-filled syringes & cartridges, pouches and sachets, and others. The blister packs segment held the largest share in 2024. The market dominance is due to the widespread use of blister packs for solid oral dosage forms such as tablets and capsules, offering superior protection against moisture, contamination, and mechanical damage. Their cost-effectiveness, ease of use, and ability to provide unit-dose packaging that supports patient compliance have further strengthened their adoption among pharmaceutical manufacturers.
Moreover, pre-filled syringes & cartridges segments are anticipated to grow at the highest CAGR during the forecast period. The segments growth is due to the increasing adoption of injectable drugs, biologics, and vaccines that require precise dosing and convenient administration formats. Pre-filled syringes and cartridges offer several advantages, including reduced risk of contamination, improved patient safety, and enhanced ease of use for both healthcare professionals and patients.
End Use Insight
On the basis of end use segment, the market is segmented into pharmaceuticals and biopharmaceutical companies, biotechnology companies, medical device companies, and others. The pharmaceuticals and biopharmaceutical companies segment held the largest market share in 2024 owing to the increasing outsourcing of packaging operations to specialized contract packaging organizations (CPOs) to enhance operational efficiency, ensure regulatory compliance, and reduce production costs. The growing demand for complex drug formulations, including biologics, injectables, and personalized medicines, has intensified the need for advanced, sterile, and high-quality packaging solutions that maintain product stability and safety.

Furthermore, the biotechnology companies segment is expected to grow at a considerable CAGR during the forecast period. The segment is driven by the increasing development of complex biologics, cell and gene therapies, and other high-value biopharmaceutical products that require specialized, temperature-controlled, and contamination-free packaging solutions. Biotechnology companies often lack in-house packaging infrastructure and therefore rely on contract packaging partners with advanced capabilities in sterile filling, cryogenic storage, and customized labelling.
Regional Insights
North America captured the largest market share of 38.33% in 2024. This can be attributed to the presence of a well-established pharmaceutical and biotechnology industry, high adoption of advanced healthcare technologies, and extensive outsourcing of packaging operations to contract packaging organizations.

U.S. Healthcare Contract Packaging Services Market Trends
The healthcare contract packaging services market in the U.S. held the largest share in 2024 owing to the country’s robust pharmaceutical and biotechnology sectors, high outsourcing of packaging operations, and strict regulatory requirements for drug safety, serialization, and traceability. The increasing production of complex biologics, injectables, and personalized medicines has further driven demand for advanced, high-quality packaging solutions.
Europe Healthcare Contract Packaging Services Market Trends
The healthcare contract packaging services market in Europe is expected to grow significantly due to the stringent regulatory environment, including the EU Falsified Medicines Directive (FMD), which mandates serialization and traceability of pharmaceutical products. Additionally, the region’s strong presence of pharmaceutical and biotechnology companies, increasing production of biologics and specialty drugs, and rising demand for patient-centric and sustainable packaging solutions are driving growth.
The Germany healthcare contract packaging services market held the largest share in 2024. The market in Germany is driven by the country’s strong pharmaceutical and biotechnology industry, high regulatory standards, and widespread adoption of advanced packaging technologies. The increasing production of complex drug formulations, including biologics and specialty medicines, has heightened the demand for specialized, high-quality, and compliant packaging solutions.
The UK healthcare contract packaging services market is anticipated to grow over the forecast period. This growth is primarily due to the increasing focus on biologics, personalized medicines, and complex drug formulations that require specialized and high-quality packaging solutions. The rising trend of outsourcing packaging operations by pharmaceutical and biotechnology companies to ensure regulatory compliance, operational efficiency, and cost-effectiveness is also driving market expansion.
Asia Pacific Healthcare Contract Packaging Services Market Trends
Asia Pacific market is projected to grow at the fastest CAGR in 2024. This growth can be attributed to various factors, such as rising healthcare expenditure and the availability of several opportunities in this region, especially in Japan, China, and India.
The China healthcare contract packaging services market is driven due to the rapid expansion of its pharmaceutical and biotechnology industries, increasing production of generic and specialty drugs, and growing adoption of advanced packaging technologies. The rising trend of outsourcing packaging operations to contract service providers helps companies reduce operational costs, ensure regulatory compliance, and accelerate time-to-market.
The Japan healthcare contract packaging services market is driven due to the country’s well-established pharmaceutical and biotechnology sectors, high demand for advanced and high-quality packaging solutions, and stringent regulatory requirements for drug safety, serialization, and traceability. The growing production of biologics, injectables, and specialty medicines, along with an increasing focus on patient-centric and user-friendly packaging formats, has further fueled market demand.
Key Healthcare Contract Packaging Services Company Insights
Market players are undertaking various strategic initiatives, such as the launch of new product partnerships, collaborations, and mergers & acquisitions, to strengthen their service portfolio and provide a competitive advantage.
Key Healthcare Contract Packaging Services Companies:
The following are the leading companies in the healthcare contract packaging services market. These companies collectively hold the largest market share and dictate industry trends.
- Integer Holdings Corporation
- Viant Technology LLC
- FLEX LTD.
- Celestica Inc.
- Sanmina Corporation
- Plexus Corp.
- Phillips-Medisize
- West Pharmaceutical Services, Inc.
- Synecco Ltd
- Catalent, Inc.
- Thermo Fisher Scientific Inc.
Recent Developments
-
In February 2025, Integer Holdings Corporation announced its participation in the MD&M West 2025 conference, where it will showcase its leadership in medical device innovation. The company also highlighted its recent acquisition of Precision Coating, a move aimed at enhancing its capabilities in precision coating and expanding its portfolio in the medical device sector.
-
In October 2024, Sanmina's division, 42Q, announced the launch of a new cloud-based Manufacturing Execution System (MES). This system aims to enhance manufacturing operations by providing real-time data and analytics to improve efficiency and quality control.
Healthcare Contract Packaging Services Market Report Scope
Report Attribute
Details
Market size value in 2025
USD 25.86 billion
Revenue forecast in 2033
USD 61.14 billion
Growth rate
CAGR of 11.36% from 2025 to 2033
Historical Year
2021 - 2023
Forecast period
2025 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2025 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Services, product type, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Thailand; South Korea; Australia; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Integer Holdings Corporation; Viant Technology LLC; FLEX LTD.; Celestica Inc.; Sanmina Corporation; Plexus Corp.; Phillips-Medisize; West Pharmaceutical Services, Inc.; Synecco Ltd; Catalent, Inc.; Thermo Fisher Scientific Inc
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Healthcare Contract Packaging Services Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare contract packaging services market report based on services, product type, end use, and region:

-
Service Outlook (Revenue, USD Million, 2021 - 2033)
-
Primary Packaging
-
Secondary Packaging
-
Tertiary Packaging
-
-
Product Type Outlook (Revenue, USD Million, 2021 - 2033)
-
Blister Packs
-
Bottles (Plastic / Glass)
-
Vials & Ampoules
-
Pre-Filled Syringes & Cartridges
-
Pouches and Sachets
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Pharmaceuticals and Biopharmaceutical Companies
-
Biotechnology Companies
-
Medical Device Companies
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Thailand
-
South Korea
-
Australia
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Share this report with your colleague or friend.
Need a Tailored Report?
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.